View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Mosunetuzumab 30, B-Non-Hodgkin Lymphoma, cycle 3+
Protocol-ID: 2107 V1.0 (Mini), MOSU30, B-NHL, C3+Indication(s)
- Mantle Cell Lymphoma; ICD-10 C83.1
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
- NHL, B-Cell Type, Follicular Grade I-IIIa; ICD-10 C82.9
- NHL, B-Cell Type, Follicular grade IIIb; ICD-10 C82.-, C82.7, C82.9
Links
- Mosunetuzumab (lunsumio) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.07.2022